MARKET

CEMI

CEMI

Chembio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.870
-0.560
-10.31%
After Hours: 4.870 0 0.00% 16:57 03/03 EST
OPEN
5.43
PREV CLOSE
5.43
HIGH
5.43
LOW
4.850
VOLUME
665.89K
TURNOVER
--
52 WEEK HIGH
15.89
52 WEEK LOW
2.250
MARKET CAP
98.26M
P/E (TTM)
-4.0261
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
POC diagnostics Market Size 2020 Demand, Global Trend, News, Business Growth, Top Key Players Update, Business Statistics and Research Methodology by Forecast to 2028
Mar 03, 2021 (The Expresswire) -- The PoC diagnostic tests facilitate quick results, hence its highly preferred by patients for their improved health. Along...
The Express Wire · 11h ago
Global POC Diagnostics Market 2020 Key Business Strategies, Technology Innovation and Regional Data Analysis to 2025
Mar 02, 2021 (CDN Newswire via Comtex) -- Global POC Diagnostics Market Growth 2020-2025 aims to fill the need of organizations of settling on the best...
CDN Newswire · 1d ago
Global Point-of-Care Infectious Disease Diagnostics or Testing Market Size 2021: Worldwide COVID-19 Impact Analysis, Business Opportunities, Industry Size & Share, Key Applications, Demands, Growth, Trends Analysis and Forecast to 2025
Mar 01, 2021 (The Expresswire) -- Global “Point-of-Care Infectious Disease Diagnostics or Testing Market” research report offers qualitative and quantitative...
The Express Wire · 1d ago
Global COVID-19 In-Vitro Diagnostics Market 2020 Company Profile, Import/Export Scenario, Business Strategies and Emerging Market Segments to 2025
Mar 01, 2021 (CDN Newswire via Comtex) -- MarketsandResearch.biz has published a report titled Global COVID-19 In-Vitro Diagnostics Market Growth (Status and...
CDN Newswire · 2d ago
Global Covid-19 Testing Market 2020 Leading Competitors, Regional Trends and Growth Trends 2025
Mar 01, 2021 (CDN Newswire via Comtex) -- Global Covid-19 Testing Market Growth (Status and Outlook) 2020-2025 is the latest excellent and defined market...
CDN Newswire · 2d ago
Global Point of Care Reader Market 2020 Upcoming Trends, Latest Innovation, Advance Technology and Top Companies to 2025
Feb 28, 2021 (CDN Newswire via Comtex) -- This study document namely Global Point of Care Reader Market 2020 by Manufacturers, Type and Application, Forecast...
CDN Newswire · 3d ago
Global COVID-19 Diagnostic Testing Market - Analysis By Test Type (Molecular, Serology), End-User, By Region, By Country (2020 Edition): Market Insights, Competition and Forecast (2020-2025)
Feb 26, 2021 (Heraldkeepers) -- Executive Summary The Global COVID-19 Diagnostic Testing Market is estimated to be valued at USD 44481.8 million for the year...
Heraldkeepers · 5d ago
Point of Care Infectious Disease Market Size, Share, Industry, Analysis, Price, Trends, Report 2020-2027
Comserve · 5d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CEMI. Analyze the recent business situations of Chembio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CEMI stock price target is 9.00 with a high estimate of 10.00 and a low estimate of 8.00.
EPS
Institutional Holdings
Institutions: 131
Institutional Holdings: 10.12M
% Owned: 50.17%
Shares Outstanding: 20.18M
TypeInstitutionsShares
Increased
21
380.88K
New
31
2.25M
Decreased
17
556.80K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.99%
Pharmaceuticals & Medical Research
-1.89%
Key Executives
Chairman/Executive Director
Gail Page
President/Chief Executive Officer/Director
Richard Eberly
Chief Financial Officer/Executive Vice President
Neil Goldman
Executive Vice President/Chief Technology Officer/Chief Scientific Officer
Javan Esfandiari
Vice President/Director of Sales/Director of Marketing
Chuck Caso
Director
David Acheson
Independent Director
Katherine Davis
Independent Director
Mary Polan
Independent Director
John Potthoff
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About CEMI
Chembio Diagnostics, Inc. is a provider of point-of-care diagnostic products for the detection and diagnosis of infectious diseases. The Company is primarily focused on expanding its product portfolio based upon its Dual Path Platform (DPP). The Company's products include rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The Company’s point-of-care infectious disease portfolio is comprised of multiple commercial products and are performed with a tiny drop of blood from the fingertip and provide results in approximately 15 minutes. The Company’s products include DPP HIV 1/2, DPP HIV-Syphilis, DPP Syphilis Screen and Confirm, DPP Zika, DPP Leishmaniasis, STAT-PAK HIV 1/2, STAT-PAK Chagas, SURE CHECK HIV 1/2 and SURE CHECK HIV 1/2 Self- Test.

Webull offers kinds of Chembio Diagnostics Inc stock information, including NASDAQ:CEMI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CEMI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CEMI stock methods without spending real money on the virtual paper trading platform.